Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
27 04 2021
Historique:
received: 18 11 2020
revised: 18 01 2021
accepted: 20 01 2021
pubmed: 3 2 2021
medline: 26 11 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

Sexual dimorphism in cancer incidence and outcome is widespread. Understanding the underlying mechanisms is fundamental to improve cancer prevention and clinical management. Sex disparities are particularly striking in kidney cancer: across diverse populations, men consistently show unexplained 2-fold increased incidence and worse prognosis. We have characterized genome-wide expression and regulatory networks of 609 renal tumors and 256 non-tumor renal tissues. Normal kidney displayed sex-specific transcriptional signatures, including higher expression of X-linked tumor suppressor genes in women. Sex-dependent genotype-phenotype associations unraveled women-specific immune regulation. Sex differences were markedly expanded in tumors, with male-biased expression of key genes implicated in metabolism, non-malignant diseases with male predominance and carcinogenesis, including markers of tumor infiltrating leukocytes. Analysis of sex-dependent RCC progression and survival uncovered prognostic markers involved in immune response and oxygen homeostasis. In summary, human kidney tissues display remarkable sexual dimorphism at the molecular level. Sex-specific transcriptional signatures further shape renal cancer, with relevance for clinical management.

Identifiants

pubmed: 33527138
pii: 6126014
doi: 10.1093/hmg/ddab031
pmc: PMC8098110
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

343-355

Subventions

Organisme : Cancer Research UK
ID : 24390
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : U01 CA155309
Pays : United States

Informations de copyright

© World Health Organization, 2021. All rights reserved. The World Health Organization has granted the Publisher permission for the reproduction of this article.

Références

Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Int J Cancer. 2012 Sep 1;131(5):E693-704
pubmed: 22213152
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Cancer Cell Int. 2020 Apr 1;20:106
pubmed: 32265595
Nat Genet. 2017 Jan;49(1):10-16
pubmed: 27869828
J Nucl Med. 2018 Sep;59(9):1340-1349
pubmed: 30042161
N Engl J Med. 2015 Nov 5;373(19):1803-13
pubmed: 26406148
Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
Hum Genomics. 2018 Mar 1;12(1):11
pubmed: 29490693
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Cancer Cell. 2016 May 9;29(5):711-722
pubmed: 27165743
PLoS Comput Biol. 2011 Jan 20;7(1):e1001057
pubmed: 21283776
Genome Res. 2012 Dec;22(12):2368-75
pubmed: 22960374
Eur Urol. 2012 Feb;61(2):258-68
pubmed: 22030119
Nat Commun. 2018 Jul 13;9(1):2720
pubmed: 30006524
Nat Genet. 2012 Jul 22;44(8):955-9
pubmed: 22820512
Bioinformatics. 2012 May 15;28(10):1353-8
pubmed: 22492648
Mol Biol Rep. 2012 Jun;39(6):6581-9
pubmed: 22297693
J Am Soc Nephrol. 2014 Oct;25(10):2327-34
pubmed: 24876115
J Immunother Cancer. 2017 Feb 21;5:18
pubmed: 28239471
Ann Oncol. 2019 Apr 1;30(4):653-655
pubmed: 30698647
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Eur J Hum Genet. 2019 Oct;27(10):1589-1598
pubmed: 31231134
Nat Rev Urol. 2015 Dec;12(12):653
pubmed: 26481574
Nat Rev Genet. 2019 Mar;20(3):173-190
pubmed: 30581192
Nat Commun. 2013;4:2771
pubmed: 24264146
Chronobiol Int. 2019 Jul;36(7):906-918
pubmed: 31014126
J Clin Invest. 2015 Jun;125(6):2375-84
pubmed: 25961457
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Int J Mol Sci. 2019 Nov 14;20(22):
pubmed: 31739444
Cancer Res. 2018 Oct 1;78(19):5527-5537
pubmed: 30275052
Pathol Oncol Res. 2020 Jul;26(3):1583-1594
pubmed: 31489573
Biochimie. 2016 May;124:34-52
pubmed: 26855171
Eur Urol. 2014 Nov;66(5):936-48
pubmed: 25047176
Am J Transl Res. 2019 Sep 15;11(9):5655-5663
pubmed: 31632537
Theranostics. 2020 Jan 12;10(5):2095-2114
pubmed: 32104500
Nature. 2017 Oct 11;550(7675):204-213
pubmed: 29022597
J Toxicol Pathol. 2019 Oct;32(4):245-251
pubmed: 31719751
Nat Genet. 2011 Jan;43(1):60-5
pubmed: 21131975
Carcinogenesis. 2009 Jul;30(7):1073-81
pubmed: 19468060
JCI Insight. 2017 Aug 3;2(15):
pubmed: 28768910
Front Neurosci. 2012 May 11;6:63
pubmed: 22593731
Biochim Biophys Acta. 2016 Aug;1857(8):1079-1085
pubmed: 27060254
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
J Exp Clin Cancer Res. 2020 Apr 23;39(1):70
pubmed: 32326970
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
BMC Biol. 2017 Feb 7;15(1):7
pubmed: 28173793
Nature. 2013 Jul 4;499(7456):43-9
pubmed: 23792563
Lancet Oncol. 2018 Jun;19(6):737-746
pubmed: 29778737
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nat Genet. 2008 Apr;40(4):430-6
pubmed: 18327256
Biomark Med. 2016 Jul;10(7):721-32
pubmed: 27339486
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Hum Mol Genet. 2014 Apr 1;23(7):1947-56
pubmed: 24242183
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Nat Genet. 2003 May;34(1):27-9
pubmed: 12669065
Cell Biol Int. 2018 Mar;42(3):303-312
pubmed: 29047187
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1931-6
pubmed: 21233420
Front Neuroendocrinol. 2014 Aug;35(3):347-69
pubmed: 24793874
Mediators Inflamm. 2015;2015:680853
pubmed: 26504360
Oncol Rep. 2018 Oct;40(4):2023-2035
pubmed: 30066941
Bioinformatics. 2008 Jul 1;24(13):1547-8
pubmed: 18467348
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3483-8
pubmed: 23378636
Eur Urol Focus. 2018 Jul;4(4):586-590
pubmed: 28753845
Int J Biol Sci. 2019 Jan 1;15(3):587-597
pubmed: 30745845
Biochim Biophys Acta. 2015 Aug;1850(8):1633-41
pubmed: 25450175
Semin Hematol. 2017 Apr;54(2):98-104
pubmed: 28637624
BMC Bioinformatics. 2016 Nov 25;17(1):483
pubmed: 27884101
Nat Commun. 2017 Jun 09;8:15724
pubmed: 28598434

Auteurs

Ruhina S Laskar (RS)

Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France.

Peng Li (P)

Laboratory of Population Health, Max Planck Institute for Demographic Research, 18057 Rostock, Germany.

Szilvia Ecsedi (S)

Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France.

Behnoush Abedi-Ardekani (B)

Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France.

Geoffroy Durand (G)

Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France.

Nivonirina Robinot (N)

Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France.

Jean-Noël Hubert (JN)

Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France.

Vladimir Janout (V)

Science and Research Center, Faculty of Health Sciences, Palacky University, 77900 Olomouc, Czech Republic.

David Zaridze (D)

Department of Epidemiology and Prevention, Russian N.N. Blokhin Cancer Research Centre, 115478 Moscow, Russian Federation.

Anush Mukeria (A)

Department of Epidemiology and Prevention, Russian N.N. Blokhin Cancer Research Centre, 115478 Moscow, Russian Federation.

Dana Mates (D)

Department of Environmental Health, National Institute of Public Health, 050463 Bucharest, Romania.

Ivana Holcatova (I)

Department of Public Health and Preventive Medicine, Charles University, Second Faculty of Medicine, 15006 Prague, Czech Republic.

Lenka Foretova (L)

Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, 60200 Brno, Czech Republic.

Beata Swiatkowska (B)

Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, 91-348 Lodz, Poland.

Zoran Dzamic (Z)

Clinic of Urology, Clinical Center of Serbia (KCS), University of Belgrade - Faculty of Medicine, 11000 Belgrade, Serbia.

Sasa Milosavljevic (S)

International Organisation for Cancer Prevention and Research, 11070 Belgrade, Serbia.

Robert Olaso (R)

Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France.

Anne Boland (A)

Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France.

Jean-François Deleuze (JF)

Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France.

David C Muller (DC)

Faculty of Medicine, School of Public Health, Imperial College London, W21NY London, UK.

James D McKay (JD)

Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France.

Paul Brennan (P)

Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France.

Florence Le Calvez-Kelm (F)

Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France.

Ghislaine Scelo (G)

Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France.
Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, 8-10124 Turin, Italy.

Estelle Chanudet (E)

Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH